Synthesis of guanidinium-sulfonimide ion pairs: towards novel ionic liquid crystals.

The recently introduced concept of ionic liquid crystals (ILCs) with complementary ion pairs, consisting of both, mesogenic cation and anion, was extended from guanidinium sulfonates to guanidinium sulfonimides. In this preliminary study, the synthesis and mesomorphic properties of selected derivatives were described, which provide the first example of an ILC with the sulfonimide anion directly attached to the mesogenic unit.

Introduction

While ionic liquids, i.e., molten salts composed of either organic cation or anion (or both) with melting points far below 100 °C, are extensively used as designer solvents, electrolytes for n class="Chemical">lithium ion batteries, dye-sensitized solar cells, and the electrochemical deposition of metals [1-5], the corresponding ionic liquids with thermotropic liquid-crystalline properties, i.e., ILCs, are a much younger class of compounds [6-8]. Although Heintz was the pioneer, who observed in 1854 melting and clearing transitions upon heating of magnesium myristate [9-10], he did not recognize this as liquid-crystalline behavior. The first regular pyridinium ILCs were reported in 1938 by Knight and Shaw [11-12], followed by seminal findings by Seddon and Bruce [13]. Regarding ionic liquids, sulfonimides have been used in various ways. Particularly interesting is the symmetrical bistriflimide anion [14], which leads to desirable properties such as hydrolytic stability, low viscosity or low melting points in the ionic liquids [1,4,15-19]. By using an elongated perfluoroalkyl chain at the bistriflimide anion in combination with short chain-substituted pyrrolidinium cations MacFarlane was able to induce plastic crystal phases and liquid-crystalline phases at room temperature [20]. Ion pairs consisting of perfluorosulfonylimide anions and imidazolium cations with short alkyl chains were studied by DesMarteau resulting in room-temperature ionic liquids [21]. In contrast, ILCs with bistriflimide anions are much less explored, because the sterically demanding anion often inhibits the formation of a mesophase [6,22]. Liquid-crystalline phases were found for viologen salts [23-28], imidazolium ILCs [29-31], pyrrolidinium ILCs [32-33] and ionic polymers [34-37]. Sulfonimides, which are directly bound to a mesogenic group, have not been described until now. We have recently described the concept of complementary ion pairs, where guanidinium sulfonate 1 with both mesogenic cation and anion displayed improved mesophase stability and increased phase widths as compared to their counterparts bearing a nonmesogenic spherical halide counterion [38-39] (Scheme 1).

Scheme 1

Complementary guanidinium sulfonate 1 and guanidinium–sulfonimide ion pairs 2 and 3.

We were thus interested, whether this concept could be also used to generate the corresponding sulfonimide ion pairs 2 and 3 with mesomorphic properties. The results of this preliminary study are discussed below.

Results and Discussion

The synthesis of guanidinium–sulfonimide ion pairs commenced with the commercially available sulfonyl chloride 4 [38], which was treated with trifluoromethanesulfonamide (5a) in the presence of NEt3 following a procedure by Hesemann and Brunel [40]. Then the fluorinated sulfonimide was converted to the potassium salt 6a after recrystallization from MeOH in 60% yield (Scheme 2).

Scheme 2

Synthesis of the potassium sulfonimides 6a and 6b.

The corresponding nonfluorinated n class="Chemical">sulfonimide K+-salt 6b was obtained by deprotonation of methanesulfonamide (5b) with NaH followed by treatment with sulfonyl chloride 4 according to a method by Dick and Townsend [41]. Analogous deprotonation with KOH yielded 6b in 71%.

The K+-salts were prepared due to their more convenient isolation as compared to the corresponding protonated compounds. However, the n class="Chemical">K+-sulfonimides 6a,b were not used for a direct methyl transfer towards the synthesis of the desired guanidinium–sulfonimide ion pairs in a similar way that the arylsulfonic acid methylesters were previously used as methyl transfer reagents [38], because we wanted to avoid the activation with dimethyl sulfate reported by DesMarteau [21]. Therefore we planned an indirect formation of the ion pairs by anion exchange via salt metathesis. In order to be successful, two requirements have to be met. First, the solubility of the sulfonimide salts 6a,b in the solvent must be sufficient. Second, one of the products must be insoluble in order to shift the equilibrium towards complete conversion. In contrast to the sodium 4-alkoxyphenylsulfonates both potassium salts 6a,b are soluble in boiling MeCN, so that both conditions for a successful salt metathesis are fulfilled.

The known guanidinium chloride 7∙Cl [42] was treated with MeI in the presence of K2CO3 to afford the N-methylated guanidinium iodide 8∙I (Scheme 3) [38-39].

Scheme 3

Synthesis of guanidinium sulfonimides 2a,b, 3a,b and iodides 7∙I, 8∙I.

However, this intermediate did not allow a salt metathesis, because the resulting KI is highly soluble in MeCN (and other organic solvents). Therefore, the intermediate was treated with AgNO3 in MeOH. The resulting N-methylated guanidinium nitrate was then reacted with 6a or 6b in MeCN to the desired ion pairs 2a and 2b in 79% and 75% yield, respectively, while the precipitating KNO3 shifted the salt metathesis to completion (Scheme 3).

The good solubility of the K+-sulfonimide salts 6a,b in MeCN was further used for a salt metathesis towards the N-protonated guanidinium–sulfonimide ion pairs 3a,b by heating 7∙Cl with 6a or 6b under reflux. The resulting ion pairs 3a and 3b were isolated in 77% and 96% yield, respectively. In comparison the guanidinium iodide 7∙I was obtained in 94% yield by heating 7∙Cl with KI in MeCN under reflux (Scheme 3). The mesomorphic properties of ion pairs 2,3 and guanidinium halides 7∙I, 7∙Cl, 8∙I were studied by differential scanning calorimetry (DSC) and polarizing optical microscopy (POM). The results of the DSC experiments are summarized in Table 1.

Table 1

Phase-transition temperatures (°C) and enthalpies (kJ mol−1) of guanidinium–sulfonimide ion pairs 2 and 3 and the corresponding guanidinium salts 7∙I, 7∙Cl and 8∙Ia.

Entry	Compound	Phase transitions (onset (°C)) and transition enthalpies (given in parentheses) (kJ mol−1) upon second heating
1	2a	Cr 61 (31.8) Ib
2	2b	Cr 93 (59.1) I
3	8∙I	Cr1 49 (8.4) Cr2 117 (25.8) Ic
4	3a	Cr1 8 (18.6) Cr2 19 (0.8) Cr3 37 (−44.9) Cr4 75 (48.6) I
5	3b	Cr1 5 (8.1) Cr2 27 (−54.4) Cr3 71 (73.1) SmA 87 (1.4) I
6	7∙I	Cr1 55 (−44.3) Cr2 130 (37.2) I
7	7∙Cl	Cr 121 (29.9) SmA 128 (0.7) Ib,d
8	1	Cr1 51 (−5.1) Cr2 99 (61.6) SmA 148 (1.9) Ic

aThe following phases were observed: Cr Crystalline, SmA Smectic A, I Isotropic. Heating rate 10 K min−1. bUpon 1st heating. cData for compounds 8∙I and 1 were taken from [38]. dData for compound 7∙Cl was taken from [42]; heating rate 5 K min−1.

N-Methylated n class="Chemical">guanidinium sulfonimides 2a,b revealed only isotropic melting at 61 °C and 93 °C, respectively (Table 1, entries 1 and 2), while N-methylated guanidinium iodide 8∙I melted at 117 °C (Table 1, entry 3). In comparison, the N-methylated guanidinium sulfonate 1 displayed a melting transition at 99 °C in the SmA phase and isotropic clearing at 148 °C (Table 1, entry 8). Thus, while the presence of the sulfonimide anions in 2a,b indeed led to a decrease of the melting point as compared to the corresponding iodide 8∙I, the formation of a smectic mesophase was completely suppressed. For protonated guanidinium sulfonimides 3a,b again a significant decrease of the melting temperature was found (75 °C and 71 °C, respectively, Table 1, entries 4 and 5) as compared to the protonated guanidinium iodide 7∙I, which melted at 130 °C into the isotropic phase (Table 1, entry 6). The protonated chloride 7∙Cl showed a melting transition at 121 °C into the SmA phase, and a clearing transition at 128 °C (Table 1, entry 7) [42]. However, while the trifluoromethyl-substituted sulfonimide 3a displayed only three crystal-to-crystal transitions at 8, 19 and 37 °C, respectively, besides isotropization at 75 °C, the corresponding methyl-substituted sulfonimide 3b showed two crystal-to-crystal transitions at 5 °C and 27 °C, respectively, a melting transition into the smectic A phase at 71 °C and a clearing point at 87 °C. Thus, sulfonimide-containing ion pair 3b indeed led to a mesophase albeit with only 16 K phase width as compared to 49 K phase width of the guanidinium sulfonate 1. The DSC traces of 3b are shown in Figure 1.

Figure 1

DSC traces of compound 3b (heating/cooling rate 10 K min−1).

POM observations of 3b upon cooling from the isotropic liquid revealed fan-shaped textures and homeotropic alignment (Figure 2) typical for SmA phases.

Figure 2

Compound 3b under crossed polarizers upon cooling from the isotropic melt (200-fold magnification). (a) Homeotropic texture at 80 °C (cooling rate 10 K min−1); (b) fan-shaped texture at 88 °C (cooling rate 1 K min−1).

The mesophase of compound 3b was investigated by X-ray scattering (WAXS and SAXS) at different temperatures. The XRD experiments revealed diffraction patterns with a single diffraction peak and a diffuse halo at 4.7 Å resulting from the alkyl chains (Figure 3). These patterns are typical for smectic mesophases and further confirm the assignment of a SmA phase based on POM observations.

Figure 3

(a) WAXS diffraction pattern of 3b at 59.5 °C (vertical magnetic field director); (b) temperature-dependent layer spacing of compound 3b.

The exact layer spacing at each temperature was determined by fitting the first-order peak with a Gaussian distribution (Figure 3 and Supporting Information File 1, Table S1) and den class="Chemical">creases with rising temperatures. To allow a comparison with the layer spacings of compounds 1 and 7∙Cl, the layer spacing of 3b was determined at a reduced temperature (Tred = 0.95∙Tiso) by linear extrapolation of the obtained data (Table 2). The obtained value of dred = 32.6 Å (Table 2) is in good agreement with the values determined for salts 7∙Cl (34.0 Å [42]) and 1 (32.2 Å [38]) bearing the same (7∙Cl) or nearly the same (N–Me instead of N–H) cation 1. As the layer spacing is much larger (32.6 Å) compared to the calculated length of the cation and anion (23–24 Å, Table 2), we propose the formation of mixed double layers with the charged heads of cation and anion pointing to each other. This packing behavior is in good agreement with those reported for guanidinium sulfonate 1 [38].

Table 2

Layer spacings of compounds 1, 7∙Cl and 3b at a common reduced temperature in comparison to the calculated molecular lengths.

Compound	Tred/[° C]	dred/[Å]	Lcalc (cation)/[Å]	Lcalc (anion)/[Å]
3b	83	32.6	23.8a	22.7a
7∙Clb	122	34.0	23.9	1.81c
1d	141	32.2	23.0	21.0

aCalculated using Chem3D Ultra, Cambridgesoft, 2011. bValues were taken from [42]. cValue was taken from [43]. dValues were taken from [38].

Conclusion

We have developed a route towards guanidinium–n class="Chemical">sulfonimide ion pairs in which both anion and cation contain mesogenic units. The replacement of a spherical halide counterion by a calamitic sulfonimide anion indeed led to a decrease of the melting points, the effect being larger for trifluorosulfonimides 2a and 3a as compared to methylsulfonimides 2b and 3b. It should be noted that Strassner has recently introduced a different concept to tune melting points in ionic liquids by electronic effects of the aryl substituent [44-45]. However, the mesogenic sulfonimide resulted in the formation of a SmA mesophase only in the case of 3b, while ion pairs 2a,b and 3a did not show any liquid-crystalline properties. Thus, the presence of mesogenic counterions could not overcome the known tendency of sulfonimides to inhibit mesomorphism.

Experimental

General Information. All reactions were carried out under a n class="Chemical">nitrogen atmosphere with Schlenk-type glassware and the solvents were dried and distilled under nitrogen prior to use. Characterization of the compounds was carried out by using the following instruments. Elemental analyses: Carlo Erba Strumentazione Elemental Analyzer, Modell 1106. NMR: Bruker Avance 500 (1H, 500 MHz; 13C, 125 MHz). IR: Bruker Vector 22 FTIR spectrometer with MKII golden gate single reflection diamond ATR system. 1H and 13C NMR spectra were recorded at room temperature and referenced to TMS (Me4Si δH = 0.0 ppm, δC = 0.0 ppm) as an internal standard. The assignment of the resonances was supported by chemical shift calculations and 2D experiments (COSY and HMBC). MS (EI): Varian MAT 711 spectrometer. Polarizing optical microscopy: Olympus BX50 polarizing microscope combined with a Linkam TP93 central controller. MS (ESI): Bruker Daltonics microTOF-Q spectrometer. Differential scanning calorimetry (DSC): Mettler-Toledo DSC 822e (heating/cooling rates were 10 K min−1). X-ray diffraction (WAXS, SAXS regions): Bruker AXS Nanostar C diffractometer employing Ni-filtered Cu Kα radiation (λ = 1.5418 Å). Melting points: Büchi SMP-20. Water content: Metrohm 831 Coulometric Karl Fischer Titrator, (generator electrode with a diaphragm), HYDRANAL-Coulomat AG and HYDRANAL-Coulomat CG solutions were used.

Compounds 4 and 5a,b are commercially available. Full characterization of compounds 1 and 8∙I is given in [38], and for compound 7∙Cl in [42]. For compounds 2b, 3a and 7∙I the following water content was determined by Karl Fischer titration: 0.38%, 0.36% and 0.13%, respectively (see Supporting Inforn class="Disease">mation File 1, Table S2).

4-(Dodecyloxy)--((trifluoromethyl)sulfonyl)benzenesulfonamide, potassium salt (6a): A mixture of n class="Chemical">trifluoromethanesulfonamide (5a) (207 mg, 1.38 mmol) and 4-(dodecyloxy)-benzenesulfonylchloride (4) (500 mg, 1.39 mmol) was dissolved in abs dichloromethane (20 mL). Abs triethylamine (1 mL, 701 mg, 6.93 mmol) was added and the resulting mixture was heated under reflux for 12 h. After cooling to room temperature the solvent was removed in vacuo, the residue was taken up in ethyl acetate (100 mL), and the hot suspension was filtered. The filtrate was evaporated to dryness and the residue was purified by flash chromatography with ethyl acetate as eluent. The resulting solid was taken up in methanol (20 mL), potassium hydroxide (78 mg, 1.39 mmol) was added, and the mixture was heated under reflux for 5 min. After cooling to 0 °C product 6a precipitated as a colorless solid. Yield: 425 mg (60%); colorless solid; mp > 300 °C; 1H NMR (500 MHz, DMSO-d6) δ 0.85 (t, J = 7.2 Hz, 3H, CH3), 1.17–1.35 (m, 16H, CH2), 1.36–1.43 (m, 2H, CH2), 1.67–1.74 (m, 2H, CH2), 4.01 (t, J = 6.5 Hz, 2H, OCH2), 6.94–7.00 (m, 2H, 3-H), 7.62–7.68 (m, 2H, 2-H) ppm; 13C NMR (125 MHz, DMSO-d6) δ 13.9 (CH3), 22.1, 25.4, 28.5, 28.68, 28.71, 28.95, 28.98, 29.0 31.3 (CH2), 67.7 (OCH2), 113.8 (C-3), 128.1 (C-2), 137.1 (C-1), 160.5 (C-4) ppm; FTIR (ATR) : 2917 (m), 2848 (m), 1597 (m), 1584 (m), 1497 (m), 1467 (m), 1387 (w), 1329 (s), 1284 (m), 1254 (m), 1232 (m), 1206 (m), 1160 (vs), 1114 (m), 1093 (s), 1058 (s), 956 (w), 867 (w), 833 (m), 801 (w), 780 (s), 746 (s), 718 (w), 683 (m) cm−1; ESIMS (m/z): 472 [M]−, 303 [M− − C12H25]; HRMS–ESI (m/z): [M]− calcd for C19H29F3NO5S2−, 472.1445; found, 472.1427.

4-(Dodecyloxy)--((methylsulfonyl)benzenesulfonamide, potassium salt (6b): n class="Chemical">Methanesulfonamide (5b) (277 mg, 2.91 mmol) was given to a suspension of sodium hydride (333 mg, 8.31 mmol) in abs DMF (10 mL) and the mixture was stirred for 1 h. After cooling to 0 °C a solution of 4-(dodecyloxy)benzenesulfonylchloride (4, 1.00 g, 2.77 mmol) in abs THF (5 mL) was added dropwise and the reaction mixture was warmed to room temperature. After being stirred for 3 days, the mixture was brought to pH 1 by the addition of concd hydrochloric acid. The solvents were removed in vacuo and the residue was taken up in dichloromethane (50 mL). The resulting solution was dried with magnesium sulfate and filtered, and the filtrate was evaporated to dryness. The residue was taken up in methanol (30 mL) and treated with potassium hydroxide (156 mg, 2.77 mmol) for 5 min. After cooling the mixture to 0 °C the product 6b precipitated as a colorless solid. Yield: 901 mg (71%); colorless solid; mp > 300 °C; 1H NMR (500 MHz, DMSO-d6) δ 0.86 (t, J = 6.8 Hz, 3H, CH3), 1.18–1.35 (m, 16H, CH2), 1.36–1.43 (m, 2H, CH2), 1.66–1.74 (m, 2H, CH2), 2.72 (s, 3H, SO2CH3), 3.98 (t, J = 6.5 Hz, 2H, OCH2), 6.86–6.92 (m, 2H, 3-H), 7.59–7.64 (m, 2H, 2-H) ppm; 13C NMR (125 MHz, DMSO-d6) δ 13.9 (CH3), 22.0, 25.4, 28.5, 28.6, 28.7, 28.90, 28.91, 28.94, 31.2 (CH2), 42.6 (SO2CH3), 67.5 (OCH2), 113.2 (C-3), 128.0 (C-2), 138.8 (C-1), 159.6 (C-4) ppm; FTIR (ATR) : 3077 (w), 2914 (s), 2849 (m), 1595 (m), 1498 (m), 1473 (m), 1394 (m), 1274 (s), 1248 (s), 1152 (s), 1126 (s), 1089 (vs), 972 (m), 831 (s), 808 (s), 721 (s), 679 (m), 590 (s), 525 (vs) cm−1; ESIMS (m/z): 418 [M]−, 340 [M− − CH3O2S + H], 249 [M− − C12H25]; HRMS–ESI (m/z): [M]− calcd for C19H32NO5S2–, 418.1727; found, 418.1728.

General procedure for the preparation of pentamethylguanidinium ion pairs (2a,b)

Potassium carbonate (144 mg, 971 μmol) and n class="Chemical">methyl iodide (207 mg, 1.46 mmol) were added to a solution of guanidinium chloride (7∙Cl, 200 mg, 485 μmol) in acetonitrile (20 mL). The resulting mixture was heated to 50 °C for 12 h and then cooled to room temperature, and the solvent was removed in vacuo. The residue was taken up in dichloromethane (20 mL) and filtered, and the filtrate was concentrated to dryness. A solution of the residue in methanol (20 mL) was treated with silver nitrate (165 mg, 971 μmol) and stirred for 12 h at room temperature under the exclusion of light. The solvent was removed under reduced pressure, the residue was taken up in dichloromethane (20 mL), and the slurry was filtered by using a Rotilabo-syringe filter. After concentration of the filtrate to dryness, the residue was taken up in acetonitrile (10 mL), and sulfonimide salt 6a or 6b (509 μmol) was added. The mixture was heated under reflux for 5 min, the solvent was removed in vacuo, and the residue was taken up in dichloromethane (20 mL). After filtration with a Rotilabo-syringe filter the solvent was removed in vacuo, and the crude product was recrystallized from ethyl acetate.

-(4-(Dodecyloxy)phenyl)-,’,’,”,”-pentamethylguanidinium ((4-(dodecyloxy)phenyl)sulfonyl)((trifluoromethyl)sulfonyl)amide (2a): Yield: 330 mg (79%); colorless solid; n class="Chemical">1H NMR (500 MHz, CDCl3) δ 0.88 (t, J = 6.8 Hz, 6H, CH3), 1.20–1.38 (m, 32H, CH2), 1.40–1.48 (m, 4H, CH2), 1.73–1.82 (m, 4H, OCH2CH2), 2.82, 3.07 (br s, 12H, N[CH3]2), 3.39 (s, 3H, NCH3), 3.94 (t, J = 6.5 Hz, 2H, OCH2), 3.97 (t, J = 6.5 Hz, 2H, OCH2), 6.87–6.95 (m, 2H, 3-H, 3”-H), 6.97–7.02 (m, 2H, 2-H), 7.88–7.92 (m, 2H, 2”-H) ppm; 13C NMR (125 MHz, CDCl3) δ 14.1 (CH3), 22.7, 25.98, 26.01, 29.11, 29.18, 29.36, 29.39, 29.40, 29.57, 29.61, 29.64, 29.67, 31.9 (CH2), 40.2 (NCH3), 40.2, 41.1 (br s, N(CH3)2), 68.3, 68.5 (OCH2), 114.1 (C-3”), 115.9 (C-3), 123.4 (C-2), 129.3 (C-2”), 134.65, 134.72 (C-1, C-1”), 157.7 (C-4), 162.0 (C-4”), 162.2 (C-1’) ppm; 19F NMR (235 MHz, CDCl3) δ −77.0 (CF3) ppm; FTIR (ATR) : 2918 (s), 2850 (m), 1611 (m), 1597 (m), 1555 (m), 1511 (m), 1473 (m), 1410 (m), 1350 (m), 1323 (s), 1288 (m), 1246 (s), 1221 (m), 1173 (vs), 1132 (s), 1093 (s), 1056 (s), 999 (s), 897 (m), 837 (m), 797 (m), 720 (w), 687 (m) cm−1; ESIMS (m/z): 390 [M]+, 222 [M+ − C12H25 + H]; ESIMS (m/z): 472 [M]−, 303 [M– − C12H25]; HRMS–ESI (m/z): [M]+ calcd for C24H44N3O+, 390.3479; found, 390.3456; HRMS–ESI (m/z): [M]− calcd for C19H29F3NO5S2–, 472.1434; found, 472.1438; DSC: Cr 61 °C [31.8 kJ mol–1] I.

-(4-(Dodecyloxy)phenyl)-,’,’,”,”-pentamethylguanidinium ((4-(dodecyloxy)phenyl)sulfonyl)(methylsulfonyl)amide (2b): Yield: 94 mg (75%); colorless solid; n class="Chemical">1H NMR (500 MHz, CDCl3) δ 0.88 (t, J = 6.9 Hz, 6H, CH3), 1.20–1.39 (m, 32H, CH2), 1.39–1.48 (m, 4H, CH2), 1.73–1.81 (m, 4H, OCH2CH2), 2.82, 3.09 (br s, 12H, N[CH3]2), 3.41 (s, 3H, NCH3), 2.90 (s, 3H, SO2CH3), 3.90–3.97 (m, 4H, OCH2), 6.82–6.87 (m, 2H, 3”-H), 6.89–6.94 (m, 2H, 3-H), 7.00–7.05 (m, 2H, 2-H), 7.87–7.92 (m, 2H, 2”-H) ppm; 13C NMR (125 MHz, CDCl3) δ 14.1 (CH3), 22.7, 26.0, 29.19, 29.20, 29.35, 29.40, 29.58, 29.64, 29.67, 31.9 (CH2), 40.3 (NCH3), 40.3, 41.2 (br s, N(CH3)2), 42.2 (SO2CH3), 68.1, 68.4 (OCH2), 113.6 (C-3”), 115.8 (C-3), 123.4 (C-2), 128.7 (C-2”), 135.0 (C-1), 137.8 (C-1”), 157.4 (C-4), 160.7 (C-4”), 162.2 (C-1’) ppm; FTIR (ATR) : 2919 (s), 2850 (m), 1612 (m), 1552 (m), 1510 (m), 1469 (m), 1403 (m), 1296 (w), 1268 (s), 1241 (s), 1177 (m), 1143 (m), 1122 (s), 1086 (s), 1051 (s), 1001 (w), 948 (w), 897 (w), 837 (m), 801 (m), 721 (s), 653 (s), 587 (vs) cm−1; ESIMS (m/z): 390 [M]+, 222 [M+ − C12H25 + H]; ESIMS (m/z): 418 [M]−, 249 [M− − C12H25]; HRMS–ESI (m/z): [M]+ calcd for C24H44N3O+, 390.3479; found, 390.3484; HRMS–ESI (m/z): [M]− calcd for C19H32NO5S2–, 418.1716; found, 418.1791; Anal. calcd for C43H76N4O6S: C, 63.82; H, 9.47; N, 6.92; found: C, 63.83; H, 9.38; N, 6.94; DSC: Cr 93 °C [59.1 kJ mol–1] I.

General procedure for the preparation of tetramethylguanidinium ion pairs (3a,b)

A mixture of guanidinium chloride (7∙Cl, 50 mg, 0.122 mmol) and sulfonimide K+-salt 6a or 6b (0.129 mmol) in acetonitrile (10 mL) was heated under reflux for 5 min. The solvent was removed under reduced pressure, the residue was taken up in dichloromethane (20 mL), and the slurry was filtered with a Rotilabo-syringe filter. After removal of all volatiles in vacuo, the residue was recrystallized from ethyl acetate to give the pure salts 3a,b.

-(4-(Dodecyloxy)phenyl)-’,’,”,”-tetramethylguanidinium ((4-(dodecyloxy)phenyl)sulfonyl)((trifluoromethyl)sulfonyl)amide (3a): Yield: 95 mg (77%), colorless solid; n class="Chemical">1H NMR (500 MHz, CDCl3) δ 0.88 (t, J = 7.0 Hz, 6H, CH3), 1.20–1.39 (m, 32H, CH2), 1.40–1.49 (m, 4H, CH2), 1.73–1.82 (m, 4H, OCH2CH2), 2.98 (br s, 12H, N(CH3)2), 3.92 (t, J = 6.6 Hz, 2H, OCH2), 3.97 (t, J = 6.6 Hz, 2H, OCH2), 6.85–6.91 (m, 4H, 3-H, 3”-H), 6.95–7.00 (m, 2H, 2-H), 7.85–7.90 (m, 2H, 2”-H) ppm; 13C NMR (125 MHz, CDCl3) δ 14.1 (CH3), 22.7, 25.99, 26.04, 29.13, 29.24, 29.36, 29.39, 29.42, 29.57, 29.59, 29.61, 29.64, 29.67, 31.9 (CH2), 40.3 (N(CH3)2), 66.3, 66.4 (OCH2), 113.9 (C-3”), 115.7 (C-3), 122.3 (C-2), 128.7 (C-2”), 130.2 (C-1), 135.6 (C-1”), 157.0 (C-4), 159.1 (C-4”), 161.6 (C-1’) ppm; 19F NMR (235 MHz, CDCl3) δ −78.1 (CF3) ppm; FTIR (ATR) : 2917 (s), 2850 (m), 1620 (m), 1595 (m), 1572 (m), 1512 (m), 1474 (m), 1423 (w), 1403 (m), 1335 (s), 1311 (m), 1296 (m), 1257 (m), 1241 (m), 1223 (m), 1195 (s), 1163 (s), 1137 (s), 1111 (w), 1091 (m), 1032 (vs), 915 (w), 828 (s), 782 (m), 752 (m), 723 (m), 685 (m), 640 (m), 598 (s), 562 (s) cm−1; ESIMS (m/z): 376 [M]+, 331 [M+ − C2H6N − H]; ESIMS (m/z): 472 [M]−, 303 [M– − C12H25]; HRMS–ESI (m/z): [M]+ calcd for C23H42N3O+, 376.3322; found: 376.3334; HRMS–ESI (m/z): [M]− calcd for C19H29F3NO5S2–, 472.1434; found, 472.1425; Anal. calcd for C42H71F3N4O6S2 (849.2): C, 59.41; H, 8.43; N, 6.60; found: C, 59.53; H, 8.36; N, 6.60; DSC: Cr1 8 °C [18.6 kJ mol−1] Cr2 19 °C [0.8 kJ mol−1] Cr3 37 °C [−44.9 kJ mol−1] Cr4 75 °C [48.6 kJ mol−1] I.

-(4-(Dodecyloxy)phenyl)-’,’,”,”-tetramethylguanidinium ((4-(dodecyloxy)phenyl)sulfonyl)(methylsulfonyl)amide (3b): Yield: 93 mg (96%); colorless solid; n class="Chemical">1H NMR (500 MHz, CDCl3) δ 0.88 (t, J = 6.9 Hz, 6H, CH3), 1.20–1.39 (m, 32H, CH2), 1.40–1.48 (m, 4H, CH2), 1.72–1.81 (m, 4H, OCH2CH2), 2.86–3.08 (m, 12H, N(CH3)2), 2.90 (s, 3H, SO2CH3), 3.92 (t, J = 6.5 Hz, 2H, OCH2), 3.96 (t, J = 6.6 Hz, 2H, OCH2), 6.83–6.89 (m, 4H, 3-H, 3”-H), 6.96–7.02 (m, 2H, 2-H), 7.85–7.90 (m, 2H, 2”-H) ppm; 13C NMR (125 MHz, CDCl3) δ 14.1 (CH3), 22.7, 26.0, 26.1, 29.16, 29.25, 29.36, 29.40, 29.42, 29.58, 29.59, 29.61, 29.64, 29.67, 31.9 (CH2), 40.4 (N(CH3)2), 42.4 (SO2CH3), 66.2, 66.3 (OCH2), 113.8 (C-3”), 115.6 (C-3), 122.2 (C-2), 128.7 (C-2”), 130.7 (C-1), 136.7 (C-1”), 156.8 (C-4), 159.2 (C-4”), 161.1 (C-1’) ppm; FTIR (ATR) : 2915 (s), 2850 (m), 1631 (m), 1597 (m), 1567 (s), 1513 (m), 1467 (m), 1434 (m), 1417 (m), 1401 (m), 1301 (w), 1271 (s), 1239 (s), 1170 (w), 1114 (s), 1079 (vs), 1061 (s), 1004 (m), 972 (m), 913 (w), 835 (s), 800 (m), 714 (s) cm−1; ESIMS (m/z): 376 [M]+, 331 [M+ − C2H6N − H]; ESIMS (m/z): 418 [M]−, 249 [M− − C12H25]; HRMS–ESI (m/z): [M]+ calcd for C23H42N3O+, 376.3322; found, 376.3331; HRMS–ESI (m/z): [M]− calcd for C19H32NO5S2–, 418.1716; found, 418.1724; Anal. calcd for C42H74N4O6S2 (795.2): C, 63.44; H, 9.38; N, 7.05; found: C, 63.55; H, 9.31; N, 7.07; DSC: Cr1 5 °C [8.1 kJ mol−1] Cr2 27 °C [−54.4 kJ mol−1] Cr3 71 °C [73.1 kJ mol−1] SmA 87 °C [1.4 kJ mol−1] I.

-(4-(Dodecyloxy)phenyl)-’,’,”,”-tetramethylguanidinium n class="Chemical">iodide (7∙I): A mixture of guanidinium chloride (7∙Cl, 400 mg, 971 μmol) and potassium iodide (493 mg, 2.97 mmol) in acetonitrile (15 mL) was heated under reflux for 5 min. After being cooled to room temperature, the solvent was removed under reduced pressure. The residue was taken up in dichloromethane (20 mL), and the resulting slurry was filtered. After evaporation of the filtrate to dryness the residue was recrystallized from ethyl acetate/acetonitrile (20:1). Yield: 446 mg (94%); colorless solid; 1H NMR (500 MHz, CDCl3) δ 0.88 (t, J = 6.9 Hz, 3H, CH3), 1.73–1.80 (m, 2H, OCH2CH2), 2.98 (br s, 12H, N(CH3)2), 3.91 (t, J = 6.6 Hz, 2H, OCH2), 6.84–6.91 (m, 2H, 3-H), 7.11–7.17 (m, 2H, 3-H), 9.93 (s, 1H, NH) ppm; 13C NMR (125 MHz, CDCl3) δ 14.1 (CH3), 22.7, 26.0, 29.22, 29.36, 29.41, 29.58, 29.61, 29.64, 29.67, 31.9 (CH2), 41.0 (br s, N(CH3)2), 68.4 (OCH2), 115.6 (C-3), 122.6 (C-2), 129.8 (C-1), 157.1, 158.4 (C-4, C-1) ppm; FTIR (ATR) : 2917 (s), 2847 (m), 1620 (s), 1558 (s), 1510 (s), 1467 (s), 1452 (m), 1417 (s), 1398 (s), 1312 (m), 1261 (m), 1229 (s), 1167 (m), 1115 (m), 1067 (m), 1024 (m), 1000 (m), 907 (w), 837 (s), 798 (w), 782 (w), 719 (m), 683 (s), 635 (m), 603 (m), 537 (m) cm−1; ESIMS (m/z): 376 [M]+, 331 [M+ − C2H6 − H]; ESIMS (m/z): 127 [M]−; HRMS–ESI (m/z): [M]+ calcd for C23H42N3O+, 376.3323; found, 376.3343; Anal. calcd for C23H42IN3O (503.5): C, 54.86; H, 8.41; N, 8.35; found: C, 54.91; H, 8.23; N, 7.97; DSC: Cr1 55 °C [−44.3 kJ mol−1] Cr2 130 °C [37.2 kJ mol−1] I.

DSC traces of compounds 2a,b, 3a and X-ray data of compound 3b.